Health-care disparities for people with multiple sclerosis

Affiliations

¹ Multiple Sclerosis International Federation, London SE1 0LX, UK. Electronic address: joanna@msif.org.
² Multiple Sclerosis International Federation, London SE1 0LX, UK.
³ National Multiple Sclerosis Society, New York, NY, USA.
⁴ Multiple Sclerosis Society of Canada, Toronto, ON, Canada.
⁵ Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine, London, UK.
⁶ Department of Pediatric Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Comment

Joanna Laurson-Doube et al. Lancet Neurol. 2020 Mar.

. 2020 Mar;19(3):207-208.

doi: 10.1016/S1474-4422(19)30486-7.

¹ Multiple Sclerosis International Federation, London SE1 0LX, UK. Electronic address: joanna@msif.org.
² Multiple Sclerosis International Federation, London SE1 0LX, UK.
³ National Multiple Sclerosis Society, New York, NY, USA.
⁴ Multiple Sclerosis Society of Canada, Toronto, ON, Canada.
⁵ Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine, London, UK.
⁶ Department of Pediatric Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

No abstract available

Comment on

Essential medicines for patients with multiple sclerosis.
The Lancet Neurology. The Lancet Neurology. Lancet Neurol. 2019 Dec;18(12):1067. doi: 10.1016/S1474-4422(19)30390-4. Lancet Neurol. 2019. PMID: 31701885 No abstract available.